# PANTOPRAZOLE SODIUM

NDC: 71610-659
Generic name: PANTOPRAZOLE
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20220501

FDA application: ANDA202882

## Active ingredients

- PANTOPRAZOLE SODIUM: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-659"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-659
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c10e9c12-e39d-4b0b-bd4c-10d3e9a4cf34
